SRY Labs: Lab Test Results
Independent Certificates of Analysis aggregated from public lab results. Not affiliated with or paid by SRY Labs.
122
CoAs on file
98.11%
Avg reported purity
14
Compounds tested
Jul 19, 2026
Latest test
Results by compound
| Compound | CoAs | Avg purity | Latest |
|---|---|---|---|
| Tirzepatide | 36 | 99.81% | Jul 19, 2026 |
| Retatrutide | 31 | 99.8% | Jun 7, 2026 |
| Tesamorelin | 12 | 98.79% | Mar 1, 2026 |
| Cagrilintide | 8 | 99.37% | May 7, 2026 |
| GHK-Cu | 7 | 99.82% | Feb 1, 2026 |
| BPC-157 | 7 | 89.4% | Nov 5, 2025 |
| TB-500 | 7 | 98.38% | Oct 8, 2025 |
| Semaglutide | 4 | 99.64% | Jan 14, 2026 |
| Sermorelin | 3 | 99.08% | Mar 5, 2026 |
| CJC-1295 DAC | 2 | 58.45% | Jun 24, 2025 |
| PT-141 | 2 | 90.75% | Jun 28, 2025 |
| CJC-1295 No DAC | 1 | 99.84% | Aug 20, 2025 |
| TB-500 Thymosin Beta-4 | 1 | 98.04% | Jan 29, 2026 |
| CJC-1295 | 1 | 99.31% | Jul 17, 2025 |
Recent CoAs
| Compound | Batch | Purity | Lab | Tested | |
|---|---|---|---|---|---|
| Tirzepatide | F21750628 | 99.9% | Lab G | Jul 19, 2026 | verify |
| Retatrutide | F21750628 | 99.8% | Lab G | Jun 7, 2026 | verify |
| Cagrilintide | n/a | 99.6% | Lab G | May 7, 2026 | verify |
| Tirzepatide | G23050728 | 99.9% | Lab E | May 5, 2026 | verify |
| Tirzepatide | n/a | 99.9% | Lab E | Apr 22, 2026 | verify |
| Retatrutide | n/a | 99.7% | Lab G | Mar 24, 2026 | verify |
| Tirzepatide | n/a | 99.7% | Lab G | Mar 24, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab E | Mar 18, 2026 | verify |
| Cagrilintide | H20830825 | 99.7% | Lab G | Mar 12, 2026 | verify |
| Sermorelin | n/a | 98.4% | Lab E | Mar 5, 2026 | verify |
| Tesamorelin | n/a | n/a | Lab E | Mar 1, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab E | Mar 1, 2026 | verify |
| Tirzepatide | n/a | 99.9% | Lab E | Mar 1, 2026 | verify |
| Tirzepatide | n/a | 99.9% | Lab E | Mar 1, 2026 | verify |
| Retatrutide | n/a | 99.8% | Lab G | Feb 19, 2026 | verify |
| Tirzepatide | n/a | 99.8% | Lab G | Feb 19, 2026 | verify |
| Tirzepatide | n/a | 99.8% | Lab G | Feb 19, 2026 | verify |
| Tirzepatide | F22650628 | 99.8% | Lab G | Feb 14, 2026 | verify |
| Retatrutide | n/a | 99.7% | Lab G | Feb 14, 2026 | verify |
| GHK-Cu | n/a | 99.9% | Lab E | Feb 1, 2026 | verify |
| Tesamorelin | G22650728 | 99.12% | Lab E | Feb 1, 2026 | verify |
| Cagrilintide | G23050728 | 98.97% | Lab E | Feb 1, 2026 | verify |
| TB-500 Thymosin Beta-4 | H20250828 | 98.04% | Lab E | Jan 29, 2026 | verify |
| Retatrutide | F21750628 | n/a | Lab E | Jan 28, 2026 | verify |
| Semaglutide | SRY S15 - (A) | 99.8% | Lab G | Jan 14, 2026 | verify |
Showing 25 most recent of 122. Search the full database on the CoA page.
Embed this badge
Sell or represent SRY Labs? Link your customers to this page with the badge below. Free, no signup. The badge and counts update as new lab results land.
<a href="https://ascendpeptide.org/coa/vendor/sry-labs/" rel="noopener"> <img src="https://ascendpeptide.org/coa/badge/sry-labs.svg" alt="SRY Labs: lab tested, 122 CoAs on file at ASCEND Peptide" width="230" height="54"> </a>
Data comes from publicly posted third-party lab certificates (Janoshik, MZ Biolabs, and others) and community submissions. Purity figures are as reported by the testing lab for the specific batch tested; they are not a guarantee of any other batch. For research and informational purposes only.